Pista A - Search Results

1

Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.

Pista A, Verdasca N, Oliveira A. Pista A, et al. J Med Virol. 2011 Feb;83(2):272-6. doi: 10.1002/jmv.21952. J Med Virol. 2011. PMID: 21181922

2

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies.

Pista A, Costa C, Saldanha C, Moutinho JAF, Moutinho JM, Arrobas F, Catalão C, Kempers J. Pista A, et al. BMC Public Health. 2019 Feb 26;19(1):235. doi: 10.1186/s12889-019-6536-4. BMC Public Health. 2019. PMID: 30808324 Free PMC article.

3

Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England.

Mendes D, Mesher D, Pista A, Baguelin M, Jit M. Mendes D, et al. Among authors: pista a. Eur J Public Health. 2018 Apr 1;28(2):343-347. doi: 10.1093/eurpub/ckx176. Eur J Public Health. 2018. PMID: 29059348

4

Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.

Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal study group. Pista A, et al. Int J Gynaecol Obstet. 2017 Oct;139(1):90-94. doi: 10.1002/ijgo.12243. Epub 2017 Jul 11. Int J Gynaecol Obstet. 2017. PMID: 28632949

5

Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia.

Oliveira A, Verdasca N, Pista Â. Oliveira A, et al. Among authors: pista a. J Med Virol. 2013 Jul;85(7):1235-41. doi: 10.1002/jmv.23590. J Med Virol. 2013. PMID: 23918542

6

[Biomarkers of cervical carcinogenesis associated with genital human papillomavirus infection].

Oliveira A, Delgado C, Verdasca N, Pista A. Oliveira A, et al. Among authors: pista a. Acta Med Port. 2013 Mar-Apr;26(2):139-44. Epub 2013 May 31. Acta Med Port. 2013. PMID: 23809746 Free article. Portuguese.

7

Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.

Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Groupa. Pista A, et al. Int J Gynecol Cancer. 2013 Mar;23(3):500-6. doi: 10.1097/IGC.0b013e318280f26e. Int J Gynecol Cancer. 2013. PMID: 23392401

8

Risk factors for human papillomavirus infection among women in Portugal: the CLEOPATRE Portugal Study.

Pista A, de Oliveira CF, Cunha MJ, Paixao MT, Real O; CLEOPATRE Portugal Study Group. Pista A, et al. Int J Gynaecol Obstet. 2012 Aug;118(2):112-6. doi: 10.1016/j.ijgo.2012.03.028. Epub 2012 May 16. Int J Gynaecol Obstet. 2012. PMID: 22608026

9

Prevalence of human papillomavirus infection in women in Portugal: the CLEOPATRE Portugal study.

Pista A, de Oliveira CF, Cunha MJ, Paixao MT, Real O; CLEOPATRE Portugal Study Group. Pista A, et al. Int J Gynecol Cancer. 2011 Aug;21(6):1150-8. doi: 10.1097/IGC.0b013e31821dd3b2. Int J Gynecol Cancer. 2011. PMID: 21792018

10

Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal.

Pista A, Oliveira A, Barateiro A, Costa H, Verdasca N, Paixão MT. Pista A, et al. J Med Virol. 2007 Dec;79(12):1889-97. doi: 10.1002/jmv.21002. J Med Virol. 2007. PMID: 17935194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results